Paper21622864
IL-13 antibodies influence IL-13 clearance in humans by modulating scavenger activity of IL-13Rα2.
Kasaian MT and 6 others. J Immunol, 2011. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. IL-13 antibodies influence IL-13 clearance in humans by modulating scavenger activity of IL-13Rα2. Papers, record 21622864. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21622864
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- IL-13 antibodies influence IL-13 clearance in humans by modulating scavenger activity of IL-13Rα2.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukin-13 | Major topic |
| Interleukin-13 Receptor alpha2 Subunit | Major topic |
| Isoantibodies | Major topic |
| Receptors, Scavenger | Major topic |
| Animals | |
| Antibody-Dependent Cell Cytotoxicity | |
| Dose-Response Relationship, Immunologic | |
| Drug Delivery Systems | |
| Extracellular Space | |
| HT29 Cells | |
| Humans | |
| Macaca fascicularis | |
| Mice | |
| Mice, Inbred BALB C |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42573974 | Context-dependent promotion of epithelial-mesenchymal transition by IL-13Rα2/STAT6 signaling in colorectal cancer. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/42573974 | PubMed |
| 39258338 | A model-based approach using GSK3772847, an anti-interleukin-33 receptor monoclonal antibody, as a showcase to predict SC administration PK and free target dynamics based on PK and total target measurements after IV administration. | CPT Pharmacometrics Syst Pharmacol | 2025 | https://conductscience.org/library/papers/39258338 | PubMed |
| 38928038 | Comparative Analysis of Orthosteric and Allosteric GLP-1R Agonists' Effects on Insulin Secretion from Healthy, Diabetic, and Recovered INS-1E Pancreatic Beta Cells. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38928038 | PubMed |
| 37554517 | Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex. | JID Innov | 2023 | https://conductscience.org/library/papers/37554517 | PubMed |
| 37310643 | Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab. | Dermatol Ther (Heidelb) | 2023 | https://conductscience.org/library/papers/37310643 | PubMed |
| 36759378 | Best Practices in mAb and Soluble Target Assay Selection for Quantitative Modelling and Qualitative Interpretation. | AAPS J | 2023 | https://conductscience.org/library/papers/36759378 | PubMed |
| 36303796 | A Mechanistic Site-Of-Action Model: A Tool for Informing Right Target, Right Compound, And Right Dose for Therapeutic Antagonistic Antibody Programs. | Front Bioinform | 2021 | https://conductscience.org/library/papers/36303796 | PubMed |
| 33559859 | Interleukin-31, a Potent Pruritus-Inducing Cytokine and Its Role in Inflammatory Disease and in the Tumor Microenvironment. | Adv Exp Med Biol | 2021 | https://conductscience.org/library/papers/33559859 | PubMed |
| 33459147 | Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumors. | MAbs | 2021 | https://conductscience.org/library/papers/33459147 | PubMed |
| 32294982 | Virus-Like Particle-Mediated Vaccination against Interleukin-13 May Harbour General Anti-Allergic Potential beyond Atopic Dermatitis. | Viruses | 2020 | https://conductscience.org/library/papers/32294982 | PubMed |
| 31866859 | The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31866859 | PubMed |
| 31557987 | Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer. | Antibodies (Basel) | 2016 | https://conductscience.org/library/papers/31557987 | PubMed |
| 31509236 | The IL-13-OVOL1-FLG axis in atopic dermatitis. | Immunology | 2019 | https://conductscience.org/library/papers/31509236 | PubMed |
| 31284553 | Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31284553 | PubMed |
| 30825336 | Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches. | Exp Dermatol | 2019 | https://conductscience.org/library/papers/30825336 | PubMed |
| 30233597 | Fra2 Overexpression in Mice Leads to Non-allergic Asthma Development in an IL-13 Dependent Manner. | Front Immunol | 2018 | https://conductscience.org/library/papers/30233597 | PubMed |
| 28455782 | RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human Study. | Adv Ther | 2017 | https://conductscience.org/library/papers/28455782 | PubMed |
| 27049478 | A mechanistic PK/PD model for two anti-IL13 antibodies explains the difference in total IL-13 accumulation observed in clinical studies. | MAbs | 2016 | https://conductscience.org/library/papers/27049478 | PubMed |
| 26132778 | IL-13 Stimulates Proliferation and Expression of Mucin and Immunomodulatory Genes in Cultured Conjunctival Goblet Cells. | Invest Ophthalmol Vis Sci | 2015 | https://conductscience.org/library/papers/26132778 | PubMed |
| 25614144 | A pharmacokinetic comparison of anrukinzumab, an anti- IL-13 monoclonal antibody, among healthy volunteers, asthma and ulcerative colitis patients. | Br J Clin Pharmacol | 2015 | https://conductscience.org/library/papers/25614144 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL13 | 3596 | Swiss-Prot's references | https://conductscience.org/library/genes/3596 | NCBI Gene |
| IL13RA1 | 3597 | PubTator's text mining | https://conductscience.org/library/genes/3597 | NCBI Gene |
| IL13RA2 | 3598 | PubTator's text mining | https://conductscience.org/library/genes/3598 | NCBI Gene |
| IL4R | 3566 | PubTator's text mining | https://conductscience.org/library/genes/3566 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21622864
GET https://conductscience.org/api/papers/v1/21622864/cited_by?page=2